Brad completed his PhD at the University of Otago (Dunedin, New Zealand) where he investigated the activation of inflammatory pathways in the brain after stroke. After a small stint as a Teaching Fellow in Pharmacology & Toxicology (University of Otago), he took up a Post-doctoral Research Fellowship with the Acute Stroke Programme, Radcliffe Department of Medicine, University of Oxford (Oxford, UK). During his time in Oxford, he formed an interest in the regulation of blood flow in the brain in health and disease. This led to studies investigating the interaction between brain tissue and the blood vessels, the signalling mechanisms that controlled energy delivery to the brain, and how these were disrupted in conditions such as stroke. In mid-2016, Brad arrived at the University of Tasmania to build the Perivascular Research Group and continue investigating the control of cerebral blood flow and blood-brain barrier function with a focus on pericytes. He has a number projects investigating the dysfunction of the neurovascular unit in brain diseases such as stroke, Alzheimer’s disease, vascular dementia, multiple sclerosis and chronic fatigue syndrome. He has received >$10 million in research grant funding including multiple NHMRC and MRFF grants, and has made significant contributions to our understanding of the vascular contributions to neurological diseases. His lab uses a wide range of in vitro methods, in vivo models and human neuropathology to assess mechanisms of neurovascular regulation in health and disease.